Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

Helping relieve headaches in school-aged children

Helping relieve headaches in school-aged children

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Nicotine products could be harmful to children

Nicotine products could be harmful to children

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Tips to prevent, treat black widow and brown recluse spider bites

Tips to prevent, treat black widow and brown recluse spider bites

UofL conducts Phase I research study for children with relapsed tumors

UofL conducts Phase I research study for children with relapsed tumors

SLU researcher awarded NIH's Cutting-Edge Basic Research Award to solve pain-killer problem

SLU researcher awarded NIH's Cutting-Edge Basic Research Award to solve pain-killer problem

Johns Hopkins endocrinologists propose new protocol for inpatient glucose management

Johns Hopkins endocrinologists propose new protocol for inpatient glucose management

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

Trial results show routine oral cholera vaccination programme protects people living in endemic regions

Trial results show routine oral cholera vaccination programme protects people living in endemic regions

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

NIH-sponsored clinical trial evaluates new investigational vaccine against West Nile Virus infection

NIH-sponsored clinical trial evaluates new investigational vaccine against West Nile Virus infection

MIT researchers reveal key brainwave changes among patients receiving nitrous oxide

MIT researchers reveal key brainwave changes among patients receiving nitrous oxide

Research finding could lead to first effective therapies, vaccines against dengue virus

Research finding could lead to first effective therapies, vaccines against dengue virus

Paclitaxel-fostamatinib combination therapy may reduce size of ovarian cancer cells

Paclitaxel-fostamatinib combination therapy may reduce size of ovarian cancer cells

St John's Wort may cause same adverse reactions as antidepressants

St John's Wort may cause same adverse reactions as antidepressants

SENRI Trial: NK1 antagonists may prevent emesis in patients treated with oxaliplatin-based chemotherapy

SENRI Trial: NK1 antagonists may prevent emesis in patients treated with oxaliplatin-based chemotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.